Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Replimune Group, Inc.REPL · Entity 4707 | Director | April 01, 2026 | April 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Replimune Group, Inc.
Report date April 01, 2026 · Filed April 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.61 · Expires 2036-04-01 | Direct | 44,500 |
Reported balance
After 2026-04-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-04-01 · Grant · Acquired 44,500 · Balance 44,500 F1: The shares underlying this option vest entirely on April 1, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares underlying this option vest entirely on April 1, 2027.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2026 Filed Apr 8, 2026 01:08 UTC | Replimune Group, Inc. REPL · Entity 4707 | GrantStock Option (right to buy) · Derivative | 44,500 | $0.00 Strike: $7.61 | $0.00 |
DisclosureSEC source: 0001104659-26-040567 · tm2611350-9_4seq1.xml · derivative · entry 1 Peeples-Dyer Veleka · CIK 0001978705 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,500 Underlying: Common Stock · 44,500 shares Expires 2036-04-01 F1 · derivative.exercise_date: The shares underlying this option vest entirely on April 1, 2027. Read SEC document |
| April 01, 2025 Filed Apr 4, 2025 00:06 UTC | Replimune Group, Inc. REPL · Entity 4707 | GrantStock Option (right to buy) · Derivative | 32,000 | $0.00 Strike: $8.40 | $0.00 |
DisclosureSEC source: 0001104659-25-031836 · tm2511407-12_4seq1.xml · derivative · entry 1 Peeples-Dyer Veleka · CIK 0001978705 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,000 Underlying: Common Stock · 32,000 shares Expires 2035-04-01 F1 · derivative.exercise_date: The shares underlying this option vest entirely on April 1, 2026. Read SEC document |
| April 01, 2024 Filed Apr 4, 2024 00:04 UTC | Replimune Group, Inc. REPL · Entity 4707 | GrantStock Option (right to buy) · Derivative | 32,000 | $0.00 Strike: $7.73 | $0.00 |
DisclosureSEC source: 0001104659-24-043259 · tm2410652-12_4seq1.xml · derivative · entry 1 Peeples-Dyer Veleka · CIK 0001978705 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,000 Underlying: Common Stock · 32,000 shares Expires 2034-04-01 F1 · derivative.exercise_date: The shares underlying this option vest entirely on April 1, 2025. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 12:13 UTC | Replimune Group, Inc. REPL · Entity 4707 | GrantEmployee Stock Option (right to buy) · Derivative | 50,400 | $0.00 Strike: $18.48 | $0.00 |
DisclosureSEC source: 0001104659-23-067858 · tm2317689-2_4seq1.xml · derivative · entry 1 Peeples-Dyer Veleka · CIK 0001978705 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,400 Underlying: Common Stock · 50,400 shares Expires 2033-06-01 F1 · derivative.exercise_date: 25% of the shares underlying this stock option vest on June 1, 2024, and the remainder of the shares underlying this stock option vest in 24 approximately equal monthly installments thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.